Business
The Caldwell Partners International Announces Retirement of Chairman and Appointment of New Directors
The Caldwell Partners International Announces Retirement of Chairman and Appointment of Ne...
About this update from Caldwell Partners International Inc.
[{"type":"text","content":"\n\n\n\nThe Caldwell Partners International Announces Retirement of Chairman and Appointment of New Directors\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, July 11, 2019\n\n\n\nTORONTO, July 11, 2019 /CNW/ - Retained executive search firm The Caldwell Partners International Inc. (\"Caldwell\" or the \"Company\") (TSX: CWL) announced today that Mr. G Edmund King, Chairman of the Company's Board of Directors (the \"Board\"), has retired as Chairman and as a member of the Board. Mr. King has served as a member of the Board since July 16, 2003, and as Chairman since March 12, 2010.\n\n \n \n\n \n\"It has been my privilege and great honour to work with and for Mr. King for the last 11 years,\" said John Wallace, Chief Executive Officer of Caldwell. \"Ed has been one of the driving forces behind our dramatic growth and international expansion, and his savvy counsel and strategic leadership has pushed us to continually greater heights. On behalf of our shareholders, stakeholders and employees, I would like thank him for his guidance, friendship and dedicated service to Caldwell.\" \nWe are pleased to announce that Mr. Elias Vamvakas has been appointed to the Board to fill the vacancy left by Mr. King's retirement. Mr. Vamvakas will also replace Mr. King as Chairman of the Board and as a member of each of the Audit Committee, Investment Committee, and Nominating/Corporate Governance/Compensation Committee of the Board.\nMr. Vamvakas is the Chairman, CEO and founder of Greybrook Capital, a private equity firm focused on real estate and healthcare. Mr. Vamvakas is also chairman of Greenbrook-TMS NeuroHealth centers, (TSX:GTMS), the leading provider of TMS therapy in North America. He is also chairman of TearLab Corporation (NASDAQ:TEAR), an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care. Prior to Greybrook Capital, Mr. Vamvakas co-founded TLCVision (NASDAQ/TLCV, TSX/TLC) where he served as Ch...